"10.1371_journal.pone.0015525","plos one","2010-12-28T00:00:00Z","Antonio Valeri; Maria Eugenia Alonso-Ferrero; Paula Río; María Roser Pujol; José A Casado; Laura Pérez; Ariana Jacome; Xabier Agirre; Maria José Calasanz; Helmut Hanenberg; Jordi Surrallés; Felipe Prosper; Beatriz Albella; Juan A Bueren","Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain; Departamento de Genética y Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain; Fundación para la Investigación Médica Aplicada (CIMA), Clínica Universidad de Navarra, Pamplona, Spain; Department of Pediatric Oncology, Hematology and Immunology, Childrens Hospital, Duesseldorf, Germany; Department of Pediatrics, Wells Center for Pediatric Research, Riley Hospital for Children, Indianapolis, Indiana, United States of America","Conceived and designed the experiments: BA FP JS JAB. Performed the experiments: AV MEA PR JAC LP RP AJ. Wrote the paper: AV MEAF PR BA FP JS JAB. Diagnosed the patients and provided samples: XA MJC. Contributed vital new reagent: HH.","H.H. may receive royalties based on a license agreement between Indiana University and Takara Shuzo, Ltd., resulting from the sale of the fibronectin fragment CH296 (Retronectin®). The other authors declare no competing financial interests.","2010","12","Antonio Valeri","AV",14,TRUE,4,7,NA,7,TRUE,FALSE,FALSE,0,NA,FALSE
